First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 1,610.10 ($21.03) and last traded at GBX 1,610.10 ($21.03), with a volume of 6 shares traded. The stock had previously closed at GBX 1,600.37 ($20.90).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Up 0.6 %
The company has a debt-to-equity ratio of 0.04, a current ratio of 9.42 and a quick ratio of 9.27. The stock has a market capitalization of £4.76 billion and a price-to-earnings ratio of -1,463.73. The firm’s fifty day moving average is GBX 1,573.49 and its 200-day moving average is GBX 1,506.40.
About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Read More
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- 3 Warren Buffett Stocks to Buy Now
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- How to Invest in the Best Canadian Stocks
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.
